PBS June updates
June 1, 2010
THE Schedule of Pharmaceutical
Benefits has, from today, been
amended to include four tablet
packs of Fosamax Plus D-Cal
(alendronate sodium with
colecalciferol and calcium
carbonate - containing the
equivalent of 70mg alendronic acid
with 140 micrograms colecalciferol
and 48 tablets calcium carbonate
1.25g - equivalent to 500 mg
calcium) for the treatment of
established osteoporosis in women
and men with facture due to
minimal trauma.
The move is in line with the with
newly released Osteoporosis
Management Guidelines from the
Royal Australian College of General
Practitioners.
“The availability of a convenient
all-in-one treatment in tablet form
should help our osteoporotic
patients get optimal protection
from fracture risk, while avoiding
the additional cost of supplements,”
said Professor John Eisman,
Director of Osteoporosis and Bone
Biology Research, Garvan Institute
of Medical Research.
Further additions to the PBS
include Clopidogrel, Tablet 75 mg
(as besilate) (Clovix 75) for the
prevention of the recurrence of
ischaemic stroke or transient
cerebral ischaemic events and the
prevention of recurrence of
myocardial infarction or unstable
angina in patients who meet
certain criteria.
The maximum quantity for
Rivaroxaban, Tablet 10 mg
(Xarelto) has also been altered to
allow the 15 tablet pack size to be
broken and the 10 tablet pack size
to not be broken, in a bid to cut
down on adequate supply confusion.
For a comprehensive list of all
PBS additions, deletions and
alterations as at 01 Jun see
www.pbs.gov.au.
The above article was sent to subscribers in Pharmacy Daily's issue from 01 Jun 10To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 01 Jun 10
